Yes, GLP-1 receptor agonists reduce appetite by acting on brain receptors that regulate hunger, leading to decreased food intake and potential weight loss
A double-blind study showed GSH reduced cisplatin toxicity and improved quality of life in ovarian cancer patients
Dietary composition significantly influences GLP-1 secretion, with specific macronutrients and food components demonstrating particular efficacy
Chronic caloric restriction can elevate cortisol as a stress response
Animal models extend further, with 90-day rat toxicology data published in 2021 showing no organ damage at doses up to 50mg/kg daily, but extrapolating rodent data to human long-term safety requires caution we don't take lightly
Furthermore, the administration of exogenous GLP-1 resulted in elevated calcitonin expression in the thyroids of normal (wild-type) mice